Maggie Ma - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Maggie Ma's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Maggie Ma

Maggie Ma

Verified

Movie Journalist and Critic, unecne.com

Los Angeles

Final Covers

sciencetravel news culture

Doesn’t Cover

drinking, gambling, smoking, drugs, abortion

Journalist Type

-

Seniority Positions

Industries

Medium Formats

Content

Total articles 13

  • CKD management in primary care: Why use SGLT2i?

    By Per-Henrik Groop, Maggie Ma Verified, Ting-Bong Chan| mims.com@ Primary care physicians, as patients’ first point of contact, play an important role in early detection and timely management of chronic kidney disease (CKD). Sodium-glucose cotransporter-2 inhibitors’ (SGLT2i) positive data in CKD trials have established their role as first-line therapy recommended by international and Hong Kong guidelines.

    By Per-Henrik Groop, Maggie Ma Verified, Ting-Bong Chan · mims.com

    Feb. 24, 2025

  • The Problem with Tutorial Traps (and how to break free)

    By Maggie Ma Verified| Medium@ Maggie Ma·Follow6 min read·--Photo by Alvaro Felipe on UnsplashPicture this with me.. You are looking for your next data science job. You have been applying to more places than you can remember, but you are not hearing back from many. You have been following @maggieindata’s content, so you know exactly what you need to include in your application — a data science portfolio to ‘show, not tell’. You watch YouTube videos to find ideas, but you didn’t like the topic.

    By Maggie Ma Verified · Medium

    Nov. 14, 2024

  • CKD management in primary care: Why use SGLT2i?

    By Per-Henrik Groop, Maggie Ma Verified, Ting-Bong Chan| mims.com@ Primary care physicians, as patients’ first point of contact, play an important role in early detection and timely management of chronic kidney disease (CKD). Sodium-glucose cotransporter-2 inhibitors’ (SGLT2i) positive data in CKD trials have established their role as first-line therapy recommended by international and Hong Kong guidelines.

    By Per-Henrik Groop, Maggie Ma Verified, Ting-Bong Chan · mims.com

    Feb. 24, 2025

As seen in

Company Info

unecne.com

Los Angeles, United States